Back to top

VRDN Maintained by RBC Capital -- Price Target Raised to $35.00

VRDN Maintained by RBC Capital -- Price Target Raised to $35.00

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Viridian Therapeutics, Inc. (VRDN)